Antibodies
30 December 2011
Roche medicine Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer29 December 2011
Peregrine Provides Update on HCV Clinical Program28 December 2011
Emergent Initiates Phase 2 Study of TRU-016 in Combination with Bendamustine in Patients with Relapsed Chronic Lymphocytic Leukemia21 December 2011
Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimer’s Disease From Merck21 December 2011
MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients with Multiple Sclerosis20 December 2011
DiaMedica’s DM-204 for Type 2 Diabetes Successfully Humanized17 December 2011
ThromboGenics and BioInvent Complete Enrolment of Phase IIb Trial with TB-402 ahead of schedule17 December 2011
AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim14 December 2011
Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses14 December 2011
Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)13 December 2011
Symphogen Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at ASH13 December 2011
Immunomedics Develops Novel Antibody-Based Therapeutics for Mantle Cell and Other Lymphomas13 December 2011
Ablynx Initiates Phase I Study With ALX-0171 for the Treatment of Respiratory Syncytial Virus (RSV)12 December 2011
ABLYNX AND MERCK SERONO SELECT A NOVEL NANOBODY CANDIDATE, ALX-0761, FOR PRE-CLINICAL DEVELOPMENT12 December 2011
Celldex Therapeutics Presents Novel Preclinical Data on CDX-1127 at the American Society of Hematology Meeting in San Diego12 December 2011
Anti-cancer activity of BI-505 demonstrated in animal modelNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports